| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 01/30/2023 | 138.1% | HC Wainwright & Co. | $15 → $2.5 | Maintains | Buy |
| 12/22/2022 | — | Oppenheimer | Downgrades | Outperform → Perform | |
| 09/12/2022 | 376.19% | Morgan Stanley | $8 → $5 | Maintains | Equal-Weight |
| 08/25/2022 | 1328.57% | Alliance Global Partners | → $15 | Initiates Coverage On | → Buy |
| 08/23/2022 | 471.43% | Truist Securities | $10 → $6 | Maintains | Hold |
| 06/22/2022 | 1328.57% | HC Wainwright & Co. | → $15 | Initiates Coverage On | → Buy |
| 04/06/2022 | — | Truist Securities | Downgrades | Buy → Hold | |
| 01/28/2022 | 757.14% | Oppenheimer | → $9 | Initiates Coverage On | → Outperform |
| 11/24/2021 | 757.14% | Morgan Stanley | → $9 | Initiates Coverage On | → Equal-Weight |
| 10/19/2021 | 1042.86% | Truist Securities | → $12 | Initiates Coverage On | → Buy |
What is the target price for Celularity (CELU)?
The latest price target for Celularity (NASDAQ: CELU) was reported by HC Wainwright & Co. on January 30, 2023. The analyst firm set a price target for $2.50 expecting CELU to rise to within 12 months (a possible 138.10% upside). 7 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Celularity (CELU)?
The latest analyst rating for Celularity (NASDAQ: CELU) was provided by HC Wainwright & Co., and Celularity maintained their buy rating.
When is the next analyst rating going to be posted or updated for Celularity (CELU)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Celularity, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Celularity was filed on January 30, 2023 so you should expect the next rating to be made available sometime around January 30, 2024.
Is the Analyst Rating Celularity (CELU) correct?
While ratings are subjective and will change, the latest Celularity (CELU) rating was a maintained with a price target of $15.00 to $2.50. The current price Celularity (CELU) is trading at is $1.05, which is out of the analyst's predicted range.
